Compared with the control 786-O-Ctrl cells, injection of 786-O-RUNX3 cells led to dramatically decreased tumor weight (Fig. 3a, P<0.05) and tumor size (Fig. 3b, P<0.05). Here, RUNX3 is linked to neoplasm.